Loosen, S. H., Schulze‐Hagen, M., Vucur, M., Gorgulho, J., Paffenholz, P., Benz, F., . . . Roderburg, C. (2021). Elevated soluble urokinase plasminogen activator receptor serum levels indicate poor survival following transarterial chemoembolization therapy for hepatic malignancies: An exploratory analysis. JGH Open.
Dyfyniad Arddull ChicagoLoosen, Sven H., et al. "Elevated Soluble Urokinase Plasminogen Activator Receptor Serum Levels Indicate Poor Survival Following Transarterial Chemoembolization Therapy for Hepatic Malignancies: An Exploratory Analysis." JGH Open 2021.
Dyfyniad MLALoosen, Sven H., et al. "Elevated Soluble Urokinase Plasminogen Activator Receptor Serum Levels Indicate Poor Survival Following Transarterial Chemoembolization Therapy for Hepatic Malignancies: An Exploratory Analysis." JGH Open 2021.